Price movement over the last 24 hours
Amphastar Pharmaceuticals Inc vs Western Union Co — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Western Union Co trades at $7.85 (market cap $2.45B). The key difference: Western Union Co is far larger — about 3× Amphastar Pharmaceuticals Inc's market cap, and Western Union Co pays a 11.99% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | WU | |
|---|---|---|
Market Cap | $826.08M | $2.45B |
Sector | Health | Technology |
52-Week High | $30.81 | $10.28 |
52-Week Low | $16.87 | $7.04 |
Enterprise Value | $1.22B | $2.14B |
Dividend Yield | — | 11.99% |
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Western Union (WU) trades at $7.84, up 0.26% on the day, with a bearish technical signal despite recent positive earnings beats. The stock shows strong profitability with a 10.88% net margin and attractive valuation ratios, including a P/E of 5.76. Recent news highlights strategic partnerships, such as the integration with Total Wireless, expanding its digital payment reach.
The outlook is mixed; low valuations and dividend yield present opportunity, but declining revenue, a recent earnings miss, and high debt pose risks. Analyst sentiment is cautious with only 12.5% buy ratings. Investors should weigh the value proposition against execution challenges in a competitive money transfer landscape.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →